Vita Life Sciences VLS.AX · AUD

Its shares trade on ASX under the ticker VLS.AX. It has been listed since 24 August 2007. In the fiscal year to 31 December 2025, it reported revenue of A$93.3m and net income of A$10.4m. At that date it held total assets of A$82.4m and shareholders' equity of A$56.3m.

Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-24. The firm is involved in the formulating, packaging, sales and distribution of vitamins and supplements. The firm's segments include health, including sale of vitamins and supplements, and investment, including general investments. The company offers products under the brands, such as Vita Health, Herbs of Gold and VitaScience, throughout the Asia-Pacific region. The firm has presence in Australia, Singapore, Malaysia and others. The firm's over the counter (OTC) products are mainly sold at pharmacies and health food stores. Its subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed BioSciences Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, Herbs of Gold (Shanghai) Co. Limited, Vita Life Science (S) Pte Limited and Sino Metro Developments Limited.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Henry TownsingNon-Executive Chairman of the Board, since 2021A$111,027
• Mr. Chin KhooChief Financial Officer, Company SecretaryA$362,600
• Mr. Andrew O'KeefeManaging Director, Executive Director, since 2016A$983,660
• Mr. K. BehCountry Manager, Malaysia and SingaporeA$523,483
• Ms. Melissa PereiraGroup Marketing ManagerA$167,627
• Mr. Shaun RutherfordHead of SalesA$464,591
• Mr. Jack TeohNon-Executive DirectorA$8,011
• Mr. Peter OsborneNon-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.